The Waning Of The Blockbuster Drug “What’s promising now are drugs that target niche diseases. That means painful restructuring ahead […]

Financial Snapshot For September 2004 In Need Of A Boost

Beleaguered Merck looks to future “A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the

FDA Eases Rules on Drug Manufacturing “Drug makers will not need regulatory approval for every change in their manufacturing processes

Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company

Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company

It’s a Perfect Storm” for Drugmakers “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving

It’s a Perfect Storm” for Drugmakers “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving

Long Trip for Psychedelic Drugs “Psychedelic drugs are inching their way slowly but surely toward prescription status in the United

Genetically altered grass spreads like wildfire “A new study shows that genes from genetically engineered grass can spread much farther